ALVOW News and Press, Alvotech Warrant

2026-03-12 20:35:00 ET The following segment was excerpted from the Royce Smaller-Companies Growth Fund FY 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Royce Smaller-Companies Growth Fund FY 2025: W...

2026-01-21 21:34:46 ET Since my October article , "My 5 Biggest Biotech Stocks Big Pharma Can Buy Now", Alvotech stock ( ALVO ) has fallen 44%, underperforming the S&P 500 [2.2% return] ( SPY ).... Read the full article on Seeking Alpha For further details se...

2025-12-23 18:08:28 ET The investment thesis I laid out in my first article about Teva Pharmaceutical ( TEVA ) has finally played out. At the time of that article, TEVA was fluctuating around $16.50-$17.00 and is now above $31.50. ... Read the full article on Seeking A...

2025-12-16 15:19:05 ET Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update December 16, 2025 12:00 PM EST... Read the full article on Seeking Alpha For further details see: Alvotech (ALVO) Discusses Launch of $125 Million Commercial ...

2025-11-13 10:51:31 ET Alvotech (ALVO) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants Benedikt Stefansson - VP of Investor Relations and Global Communications Robert Wessman - CEO, Founder & Executive Chairman Joseph McClellan - Chief ...

2025-11-03 14:07:04 ET I'm initiating Alvotech ( ALVO ) with a Hold rating because, while it has several biosimilars approved, like the biosimilar to Humira (adalimumab) in the U.S. of Simlandi (AVT02) and the biosimilar to Stelara (ustekinumab) in the U.S. of Selarsdi, it had t...

2025-10-31 10:39:51 ET Yes, as always, I'll start with a quote , but today it's from "A Farewell to Arms," by my favorite writer, Ernest Hemingway.... Read the full article on Seeking Alpha For further details see: AbbVie: Why Q3 Confirms Its Immunology Dominance

2025-10-14 08:58:15 ET Since the publication of my article , "Why Johnson & Johnson Stock Still Has Room to Run," Johnson & Johnson's ( JNJ , JNJ:CA ) share price has risen 12%.... Read the full article on Seeking Alpha For further details see: Johnso...

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...

2025-09-25 11:42:45 ET Just over four months have passed since the publication of my last article , "Why Investors Should Watch Teva Despite Regional Risks," and during that time, the Teva Pharmaceutical Industries Limited (TEVA) share price has risen by 14%.... Read the full ...